Hepatitis A Virus VP3 May Activate Serum Response Element Associated Transcription

References

• Yokosuka O. Molecular biology of hepatitis A virus: significance of various substitutions in the hepatitis A virus genome. J Gastroenterol Hepatol 2000; 15 Suppl:D91–7.
   PubMed Web of Science ®Google Scholar
• Kanda T, Yokosuka O, Ehata T, Maru Y, Imazeki F, Saisho H, et al. Detection of GBV-C RNA in patients with non-A-E fulminant hepatitis by reverse-transcription polymerase chain reaction. Hepatology 1997; 25: 1261–5.
   PubMed Web of Science ®Google Scholar
• Kanda T, Yokosuka O, Ikeuchi T, Seta T, Kawai S, Imazeki F, et al. The role of TT virus infection in acute viral hepatitis. Hepatology 1999; 29: 1905–8.
   PubMed Web of Science ®Google Scholar
• Akriviadis EA, Redeker AG. Fulminant hepatitis A in intravenous drug users with chronic liver diseases. Ann Intern Med 1989;110: 838–9.
   PubMed Web of Science ®Google Scholar
• Keeffe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver disease? Am J Gastroenterol 1995;90: 201–5.
   PubMed Web of Science ®Google Scholar
• Vento S, Garofano T, Renzini C, Camelli F, Casali F, Ghironzi G, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998;338: 286–90.
   PubMed Web of Science ®Google Scholar
• Fagan EA, Williams R. Fulminant viral hepatitis. Br Med Bull 1990;46: 462–80.
   PubMed Web of Science ®Google Scholar
• Durst RY, Goldsmidt N, Namestnick J, Safadi R, lian Y. Familial cluster of fulminant hepatitis A infection. J Clin Gastroenterol 2001; 32: 453–4.
   PubMed Web of Science ®Google Scholar
• Fujiwara K, Yokosuka O, Fukai K, Imazeki F, Saisho H, Omata M. A virus genome in sera from patients with fulminant and self-limited acute type A hepatitis. J Hepatol 2001;35: 112–9.
   PubMed Web of Science ®Google Scholar
• Totsuka A, Moritsugu Y. Hepatitis A virus proteins. Intervirology 1999;42: 63–8.
   PubMed Web of Science ®Google Scholar
• Cuthbert JA. Hepatitis A. Analysis of full-length hepatitis old and new. Clin Microbiol Rev 2001; 14: 38–58.
   PubMed Web of Science ®Google Scholar
• Probst C, Jecht M, Gauss-Muller V. Intrinsic signals for the assembly of hepatitis A virus particles: role of structural proteins VP4 and 2A. J Biol Chem 1999; 274: 4527–31.
   PubMed Web of Science ®Google Scholar
• Cohen JI, Ticehurst JR, Purcell RH, Buckler-White A, Baroudy BM. Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol 1987; 61: 50–9.
   PubMed Web of Science ®Google Scholar
• Jia XY, Summers DF, Ehrenfeld E. Primary cleavage of the HAV capsid protein precursor in the middle of the proposed 2A coding region. Virology 1993;193: 515–9.
   PubMed Web of Science ®Google Scholar
• Martin A, Escriou N, Chao SF, Girard M, Lemon SM, Wychowski C. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts. Virology 1995; 213: 213–22.
   PubMed Web of Science ®Google Scholar
• Probst C, Jecht M, Gauss-Muller V. Proteinase 3C-mediated processing of VP1-2A of two hepatitis A virus strains: in vivo evidence for cleavage at amino acid position 273/274 of VP1. J Virol 1997;71: 3288–92.
   PubMed Web of Science ®Google Scholar
• Krajcsi P, Wold WSM. Viral proteins that regulate cellular signaling. J Gen Virol 1998;79: 1325–35.
   Web of Science ®Google Scholar
• Murakami S. Hepatitis B virus X protein: structure, function and biology. Intervirology 1999; 42: 81–99.
   PubMed Web of Science ®Google Scholar
• Pan J, Duan LX, Sun BS, Feitelson MA. Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kB. J Gen Virol 2001;82: 171–82.
   PubMed Web of Science ®Google Scholar
• Otsuka M, Kato N, Lan KH, Yoshida H, Kato J, Goto T, et al. Hepatitis C virus core protein enhances p53 function through augmentation of DNA-binding affinity and transcriptional ability. J Biol Chem 2000; 275: 34122–30.
   PubMed Web of Science ®Google Scholar
• Kato N, Yoshida H, Ono-Nita SK, Kato J, Goto T, Otsuka M, et al. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology 2000;32: 405–12.
   PubMed Web of Science ®Google Scholar
• Borowski P, zur Wiesch JS, Resch K, Feucht H, Laufs R, Schmitz H. Protein kinase C recognizes the protein kinase A- binding motief of nonstructural protein 3 of hepatitis C virus. J Biol Chem 1999; 274: 30722–8.
   PubMed Web of Science ®Google Scholar
• Galien R, Emanoil-Ravier R, Mercier G. Differential effects of c-jun and CREB on c-AMP response element activation by Haras. Oncogene 1994;9: 1101–8.
   PubMed Web of Science ®Google Scholar
• Hill CS, Marais R, John S, Wynne J, Dalton S, Treisman R. Functional analysis of growth factor-responsive transcription factor complex. Cell 1993; 73: 395–406.
   PubMed Web of Science ®Google Scholar
• Marais R, Wynne J, Treisman R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 1993;73: 381–93.
   PubMed Web of Science ®Google Scholar
• Galang CK, Der CJ, Hauser CA. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c Ets-2 binding sites. Oncogene 1994; 9: 2913–21.
   PubMed Web of Science ®Google Scholar
• Minden A, Lin A, McMahon M, Lange-Carter C, Derijiard B, Davis RJ, et al. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 1994;266: 1719–23.
   PubMed Web of Science ®Google Scholar
• Schmid RM, Adler G. NF-kB/Rel/IkB: implications in gastrointestinal diseases. Gastroenterology 2000; 118: 1208–28.
   PubMed Web of Science ®Google Scholar
• Fujiwara K, Yokosuka O, Ehata T, Imazeki F, Saisho H. PCR-SSCP analysis of 5′-nontranslated region of hepatitis A viral RNA: comparison with clinicopathological features of hepatitis A. Dig Dis Sci 2000; 45: 2422–7.
   PubMed Web of Science ®Google Scholar
• Niwa H, Yamamura K, Miyazaki J. Efficient selection for highexpression transfectants with a novel eukaryotic vector. Gene 1991; 108: 193–200.
   PubMed Web of Science ®Google Scholar
• Gey GO, Coffman WD, Kubicek MT. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 1952;12: 264–5.
   Web of Science ®Google Scholar
• Gluzman Y. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 1983;23: 175–82.
   Web of Science ®Google Scholar
• Gosert R, Cassinotti P, Stiegel G, Weitz M. Identification of hepatitis A virus non-structural protein 2B and its release by the major virus protease 3C. J Gen Virol 1996; 77: 247–55.
   PubMed Web of Science ®Google Scholar
• Jecht M, Probst C, Gauss-Muller V. Membrane permeability induced by hepatitis A virus proteins 2B and 2BC and proteolytic processing of HAV 2BC. Virology 1998; 252: 218–27.
   PubMed Web of Science ®Google Scholar
• Malcolm BA, Chin SM, Jewell DA, Stratton-Thomas JR, Thudium KB, Ralston R, et al. Expression and characterization of recombinant hepatitis A virus 3C proteinase. Biochemistry 1992; 31: 3358–63.
   PubMed Web of Science ®Google Scholar
• Probst C, Jecht M, Gauss-Muller V. Processing of proteinase precursors and their effect on hepatitis A virus particle formation. J Virol 1998;72: 8013–20.
   PubMed Web of Science ®Google Scholar
• Updike WS, Tesar M, Ehrenfeld E. Detection of hepatitis A virus proteins in infected BS-C-1 cells. Virology 1991; 185: 411–8.
   PubMed Web of Science ®Google Scholar
• Kusov Y, Gauss-Muller V. Improving proteolytic cleavage at the 3A/3B site of the hepatitis A virus polyprotein impairs processing and particle formation, and the impairment can be complemented in trans by 3AB and 3ABC. J Virol 1999; 73: 9867–78.
   PubMed Web of Science ®Google Scholar
• Maltese E, Bucci M, Macchia S, Latorre P, Pagnotti P, Pierangeli A, et al. Inhibition of cap-dependent gene expression induced by protein 2A of hepatitis A virus. J Gen Virol 2000;81: 1373–81.
   PubMed Web of Science ®Google Scholar
• Luo H, Yanagawa B, Zhang J, Luo Z, Zhang M, Esfandiarei M, et al. Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J Virol 2002; 76: 3365–73.
   PubMed Web of Science ®Google Scholar
• Iordanov MS, Paranjape JM, Zhou A, Wong J, Williams BR, Meurs EF, et al. Activation of p38 mitogen-activated protein kinase and c-JUN NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol Cell Biol 2000; 20: 617–27.
   PubMed Web of Science ®Google Scholar
• Gustin KE, Sarnow P. Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. EMBO J 2001; 20: 240–9.
   PubMed Web of Science ®Google Scholar
• Gustin KE, Sarnow P. Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. J Virol 2002;76: 8787–96.
   PubMed Web of Science ®Google Scholar
• Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 1996;8: 205–15.
   PubMed Web of Science ®Google Scholar
• Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997;9: 180–6.
   PubMed Web of Science ®Google Scholar
• Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, Cobb MH, et al. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J 1995;14: 951–62.
   PubMed Web of Science ®Google Scholar
• Treisman R. Ternary complex factors: growth factor regulated transcriptional activators [review], Curr Opin Genet Dev 1994;4: 96–101.
   PubMed Web of Science ®Google Scholar
• Hill CS, Treisman R. Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. EMBO J 1995;14: 5037–47.
   PubMed Web of Science ®Google Scholar
• Hu J, Seeger C. Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc Natl Acad Sci USA 1996;93: 1060–4.
   PubMed Web of Science ®Google Scholar
• Cho G, Park SG, Jung G. Localization of HSP90 binding sites in the human hepatitis B virus polymerase. Biochem Biophys Res Commun 2000;269:191–6.
   PubMed Web of Science ®Google Scholar
• Cho G, Suh SW, Jung G. HBV polymerase interacts independently with N-terminal and C-terminal fragments of Hsp90beta. Biochem Biophys Res Commun 2000; 274: 203–11.
   PubMed Web of Science ®Google Scholar
• Gomara MJ, Riedemann S, Vega I, Ibarra H, Ercilla G, Haro I. Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis A virus infection. J Immunol Methods 2000; 234: 23–34.
   PubMed Web of Science ®Google Scholar
• Khudyakov YE, Lopareva EN, Jue DL, Fang S, Spelbring J, Krawczynski K, et al. Antigenic epitopes of the hepatitis A virus polyprotein. Virology 1999; 260: 260–72.
   PubMed Web of Science ®Google Scholar
• Ping LH, Jansen R, Stapleton J, Cohen J, Lemon S. Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus. Proc Natl Acad Sci USA 1988; 85: 8281–5.
   PubMed Web of Science ®Google Scholar
• Pinto RM, Gonzalez-Dankaart JF, Sanchez G, Guix S, Gomara MJ, Garcia M, et al. Enhancement of the immunogenicity of a synthetic peptide bearing a VP3 epitope of hepatitis A virus. FEBS Lett 1998;38: 106–10.
   Web of Science ®Google Scholar
• Stapleton JT, Frederick J, Meyer B. Hepatitis A virus attachment to cultured cell lines. J Infect Dis 1991;164: 1098–103.
   PubMed Web of Science ®Google Scholar
• Brivanlou AH, Darnell Jr. JE. Signal transduction and the control of gene expression. Science 2002;295: 813–8.
   PubMed Web of Science ®Google Scholar
• White E. Regulation of apoptosis by adenovirus EIA and E1B oncogenes. Semin Virol 1998;8: 505–13.
   Web of Science ®Google Scholar
• Brack K, Frings W, Dotzauer A, Vallbracht A. A cytopatho-genic, apoptosis-inducing variant of hepatitis A virus. J Virol 1998; 72: 3370–6.
   PubMed Web of Science ®Google Scholar
• Gosert R, Egger D, Bienz K. A cytopathic and a cell culture adapted hepatitis A virus strain differ in cell killing but not in intracellular membrane rearrangements. Virology 2000; 266: 157–69.
   PubMed Web of Science ®Google Scholar
• Avantaggiati ML, Natoli G, Balsano C, Chirillo P, Artini M, De Marzio E, et al. The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements. Oncogene 1993; 8: 1567–74.
   PubMed Web of Science ®Google Scholar
• Benn J, Schneider RJ. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA 1994; 91: 10350–4.
   PubMed Web of Science ®Google Scholar
• Doria M, Klein N, Lucito R, Schneider RJ. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J 1995; 14: 4747–57.
   PubMed Web of Science ®Google Scholar
• Lucito R, Schneider RJ. Hepatitis B virus X protein activates transcription factor NF-kB without a requirement for protein kinase C. J Virol 1992; 66: 983–91.
   PubMed Web of Science ®Google Scholar
• Jakschies D, Zachoval R, Muller R, Manns M, Nolte K-U, Hochkeppel H-K, et al. Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C. Hepatology 1994; 19: 857–65.
   PubMed Web of Science ®Google Scholar